Compare GOSS & JXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GOSS | JXG |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | China |
| Employees | N/A | 95 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.8M | 98.9M |
| IPO Year | 2018 | N/A |
| Metric | GOSS | JXG |
|---|---|---|
| Price | $0.17 | $10.00 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $4.19 | N/A |
| AVG Volume (30 Days) | ★ 15.1M | 5.1K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $48,471,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $201.64 | N/A |
| P/E Ratio | ★ N/A | $0.77 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.14 | $0.23 |
| 52 Week High | $3.87 | $11.80 |
| Indicator | GOSS | JXG |
|---|---|---|
| Relative Strength Index (RSI) | 34.86 | 69.08 |
| Support Level | $0.16 | $3.57 |
| Resistance Level | $0.36 | $10.09 |
| Average True Range (ATR) | 0.02 | 0.70 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 47.73 | 61.27 |
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products. The Company's operations are located in the PRC and all of the Company's revenue is derived from sales to customers in the PRC region.